How Should We Stop Private Equity Firms From Exploiting Public Health Insurance?
- Published in:
- AMA Journal of Ethics, 2025, v. 27, n. 5, p. 346, doi. 10.1001/amajethics.2025.346
- By:
- Publication type:
- Article
Works by Singh, Yashaswini
Results: 13
1
2
Private Equity Penetration in Behavioral Health in the United States, 2010–2022.
- Published in:
- 2025
- By:
- Publication type:
- Letter
3
Site‐based payment differentials for ambulatory services among individuals with commercial insurance.
- Published in:
- Health Services Research, 2022, v. 57, n. 5, p. 1165, doi. 10.1111/1475-6773.13935
- By:
- Publication type:
- Article
4
Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 9, p. e222886, doi. 10.1001/jamahealthforum.2022.2886
- By:
- Publication type:
- Article
5
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 8, p. e222570, doi. 10.1001/jamahealthforum.2022.2570
- By:
- Publication type:
- Article
6
Geographic Variation in Private Equity Penetration Across Select Office-Based Physician Specialties in the US.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 4, p. e220825, doi. 10.1001/jamahealthforum.2022.0825
- By:
- Publication type:
- Article
7
Growth of Private Equity and Hospital Consolidation in Primary Care and Price Implications.
- Published in:
- JAMA Health Forum, 2025, v. 6, n. 1, p. e244935, doi. 10.1001/jamahealthforum.2024.4935
- By:
- Publication type:
- Article
8
Trends in Private Equity Consolidation in Cardiovascular Care.
- Published in:
- JAMA Health Forum, 2024, v. 5, n. 6, p. e241478, doi. 10.1001/jamahealthforum.2024.1478
- By:
- Publication type:
- Article
9
Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care Program.
- Published in:
- Milbank Quarterly, 2022, v. 100, n. 1, p. 190, doi. 10.1111/1468-0009.12546
- By:
- Publication type:
- Article
10
High-Performance Plasmonic Biosensor for Blood Cancer Detection: Achieving Ultrahigh Figure-of-Merit.
- Published in:
- Plasmonics, 2025, v. 20, n. 4, p. 2083, doi. 10.1007/s11468-024-02429-8
- By:
- Publication type:
- Article
11
Highly Sensitive Plasmonic Biosensor for the Detection of Chikungunya Virus Employing TiO<sub>2</sub> and BP/WS<sub>2</sub> Heterostructure.
- Published in:
- Plasmonics, 2024, v. 19, n. 6, p. 3233, doi. 10.1007/s11468-024-02242-3
- By:
- Publication type:
- Article
12
Factors Associated With Public Trust in Pharmaceutical Manufacturers.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e233002, doi. 10.1001/jamanetworkopen.2023.3002
- By:
- Publication type:
- Article
13
Private Equity Acquisitions and Industry Payments in Ophthalmology.
- Published in:
- JAMA Ophthalmology, 2025, v. 143, n. 4, p. 360, doi. 10.1001/jamaophthalmol.2025.0002
- By:
- Publication type:
- Article